SR One Capital Management

What is SR One Capital Management?

SR One Capital Management is a biotechnology venture capital firm that focuses on translating innovative science into medicine. With an investment range from $50,000 to $50,000,000 and a sweet spot at $25,000,000, SR One supports companies at various stages including Seed, Series A, and Series B.

They adopt a 'back-and-build' approach in their investment methodology. This means they look for companies with strong underlying fundamentals, clear development pathways, and novel approaches to addressing diseases. Their mission encompasses powering the arc of innovation from science to medicine, assisting in transforming today's scientific discoveries into the medicines of tomorrow.

SR One has a strategic transatlantic presence with an investing team based in key biotechnology hubs on the West Coast of the United States and in London, UK. This geographic diversity offers SR One the ability to access high-quality science and investment opportunities across different geographies. Furthermore, this positioning allows for real-time operational support and mining of opportunities for their portfolio companies.

The industries they target include Medical Devices and Hospital Services, Healthcare and Wellness, Online Social platforms, as well as Pharmaceuticals and Medicine. SR One's commitment to partnership with founders and entrepreneurs highlights their collaborative approach in the venture capital ecosystem, seeking to act as a strategic partner that helps reimagine and advance the intersection of science and health solutions.